{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:43:12Z","timestamp":1793248992630,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijcard.2018.04.042","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T11:46:25Z","timestamp":1530099985000},"page":"68-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study"],"prefix":"10.1016","volume":"267","author":[{"given":"Daniela","family":"Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-6071","authenticated-orcid":false,"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Migliaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-9385","authenticated-orcid":false,"given":"Corrado","family":"Lodigiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Coffetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Facchinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Serricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catello","family":"Mangione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Masottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-574X","authenticated-orcid":false,"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualtiero","family":"Palareti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.04.042_bb0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0010","series-title":"American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","first-page":"e576S","article-title":"Antithrombotic and thrombolytic therapy for Valvular disease: antithrombotic therapy and prevention of thrombosis","volume":"141","author":"Whitlock","year":"2012"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0015","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-5223(19)32565-6","article-title":"Mitral replacement: the shielded ball valve prosthesis","volume":"42","author":"Starr","year":"1961","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"70","author":"Nishimura","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Joint Task Force on the Management of Valvular Heart Disease of the European Society of C","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2016.06.026","article-title":"Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis: a nationwide population-based study","volume":"181","author":"Labaf","year":"2016","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ahj.2010.05.005","article-title":"LOWERing the INtensity of oral anticoaGulant therapy in patients with bileaflet mechanical aortic valve replacement: results from the \"LOWERING-IT\" trial","volume":"160","author":"Torella","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","article-title":"Optimal oral anticoagulant therapy in patients with mechanical heart valves","volume":"333","author":"Cannegieter","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0045","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","article-title":"An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation","volume":"335","author":"Hylek","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - results from SPORTIF III and IV","volume":"167","author":"White","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0055","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1503\/cmaj.081659","article-title":"Effect of an interactive voice response system on oral anticoagulant management","volume":"180","author":"Oake","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mtc.2002.121162","article-title":"Better anticoagulation control improves survival after valve replacement","volume":"123","author":"Butchart","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124719","article-title":"The Italian START-register on anticoagulation with focus on atrial fibrillation","volume":"10","author":"Antonucci","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0049-3848(95)00061-U","article-title":"A partial factor v deficiency in anticoagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme","volume":"78","author":"Tripodi","year":"1995","journal-title":"Thromb. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2018.04.042_bb0075","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","author":"Expert Committee on the D, Classification of Diabetes M","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.2005.071183","article-title":"Valve disease-thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations","volume":"93","author":"Roudaut","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception- cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0095","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2009-02-207928","article-title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy","volume":"114","author":"Witt","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0100","series-title":"American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","first-page":"e44S","article-title":"Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis","volume":"141","author":"Ageno","year":"2012"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0105","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2009.05.046","article-title":"Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years","volume":"54","author":"Poli","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144314","article-title":"Center-related determinants of VKA anticoagulation quality: a prospective, multicenter evaluation","volume":"10","author":"Tosetto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0115","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.thromres.2014.02.031","article-title":"Mechanical heart valve prosthesis and warfarin - treatment quality and prognosis","volume":"133","author":"Grzymala-Lubanski","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12959-014-0029-6","article-title":"Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden","volume":"12","author":"Labaf","year":"2014","journal-title":"Thromb. J."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0125","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0140","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jtcvs.2008.06.030","article-title":"Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio","volume":"137","author":"Dentali","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.04.042_bb0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.04.042_bb0155","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1136\/heartjnl-2014-305486","article-title":"Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe","volume":"100","author":"De Caterina","year":"2014","journal-title":"Heart"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318301608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318301608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T14:30:56Z","timestamp":1661524256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318301608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"alternative-id":["S0167527318301608"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.042","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}